<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font32 { font-size : 32; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font24 { font-size : 24; } .font25 { font-size : 25; } .font29 { font-size : 29; }</style>
 <body>
  <p>
   <span class="font32">WIPO </span>
   <span class="font29">Re:Search </span>
   <span class="font25">diseases </span>
   <span class="font24">R&amp;amp;D </span>
   <span class="font24">[]. </span>
   <span class="font22">drug </span>
   <span class="font22">development </span>
   <span class="font21">tropical </span>
   <span class="font21">BVGH </span>
   <span class="font20">product </span>
   <span class="font20">{border-style </span>
   <span class="font19">collaborations </span>
   <span class="font19">px;} </span>
   <span class="font18">#ffffff;} </span>
   <span class="font18">online: </span>
   <span class="font17">Health </span>
   <span class="font17">disease </span>
   <span class="font17">access </span>
   <span class="font16">companies </span>
   <span class="font16">pharmaceutical </span>
   <span class="font16">March </span>
   <span class="font16">new </span>
   <span class="font16">research </span>
   <span class="font15">Professor </span>
   <span class="font15">global </span>
   <span class="font15">Global </span>
   <span class="font15">Merck </span>
   <span class="font15">countries </span>
   <span class="font15">malaria </span>
   <span class="font14">Tropical </span>
   <span class="font14">discovery </span>
   <span class="font14">funding </span>
   <span class="font14">health </span>
   <span class="font14">target </span>
   <span class="font14">company </span>
   <span class="font14">critical </span>
   <span class="font14">including </span>
   <span class="font14">px; </span>
   <span class="font14">resources </span>
   <span class="font14">{font-family </span>
   <span class="font13">Development </span>
   <span class="font13">Diseases </span>
   <span class="font13">Dr. </span>
   <span class="font13">article </span>
   <span class="font13">compounds </span>
   <span class="font13">expertise </span>
   <span class="font13">font-size </span>
   <span class="font13">needs </span>
   <span class="font13">poverty </span>
   <span class="font13">sharing </span>
   <span class="font13">treatment </span>
   <span class="font13">Co., </span>
   <span class="font13">Eisai </span>
   <span class="font13">Johnson </span>
   <span class="font13">Personal </span>
   <span class="font13">SDG </span>
   <span class="font13">Ventures </span>
   <span class="font13">address </span>
   <span class="font13">collaboration </span>
   <span class="font13">communication </span>
   <span class="font13">double; </span>
   <span class="font13">drugs </span>
   <span class="font13">international </span>
   <span class="font13">million </span>
   <span class="font13">partnership </span>
   <span class="font13">partnerships </span>
   <span class="font13">products </span>
   <span class="font13">projects </span>
   <span class="font13">resistance </span>
   <span class="font12">Access </span>
   <span class="font12">Consortium </span>
   <span class="font12">February </span>
   <span class="font12">MSD </span>
   <span class="font12">Malaria </span>
   <span class="font12">Medicine </span>
   <span class="font12">Members </span>
   <span class="font12">Research </span>
   <span class="font12">Sustainable </span>
   <span class="font12">Target </span>
   <span class="font12">University </span>
   <span class="font12">World </span>
   <span class="font12">available </span>
   <span class="font12">border-color </span>
   <span class="font12">border-width </span>
   <span class="font12">dengue </span>
   <span class="font12">develop </span>
   <span class="font12">developed </span>
   <span class="font12">efforts </span>
   <span class="font12">endemic </span>
   <span class="font12">estimated </span>
   <span class="font12">high-quality </span>
   <span class="font12">human </span>
   <span class="font12">identified </span>
   <span class="font12">infectious </span>
   <span class="font12">inhibitors </span>
   <span class="font12">innovative </span>
   <span class="font12">interested </span>
   <span class="font12">membership </span>
   <span class="font12">need </span>
   <span class="font12">needed </span>
   <span class="font12">neglected </span>
   <span class="font12">opportunities </span>
   <span class="font12">partners </span>
   <span class="font12">people </span>
   <span class="font12">potential </span>
   <span class="font12">poverty, </span>
   <span class="font12">researchers </span>
   <span class="font12">scientists </span>
   <span class="font12">solid; </span>
   <span class="font12">treat </span>
   <span class="font12">unmet </span>
   <span class="font12">valuable </span>
   <span class="font12">{font-style </span>
   <span class="font12">{font-weight </span>
   <span class="font12">(including </span>
   <span class="font12">.World </span>
   <span class="font12">African </span>
   <span class="font12">BIO </span>
   <span class="font12">BVGHâ€™s </span>
   <span class="font12">Dengue </span>
   <span class="font12">Johnson; </span>
   <span class="font12">KGaA </span>
   <span class="font12">KGaA; </span>
   <span class="font12">Ltd.; </span>
   <span class="font12">MSD; </span>
   <span class="font12">Mectizan </span>
   <span class="font12">Onchocerca </span>
   <span class="font12">Organization </span>
   <span class="font12">Partnership </span>
   <span class="font12">Product </span>
   <span class="font12">Table </span>
   <span class="font12">academic </span>
   <span class="font12">academic/non-profit </span>
   <span class="font12">accelerate </span>
   <span class="font12">activity </span>
   <span class="font12">advance </span>
   <span class="font12">antimalarial </span>
   <span class="font12">assets </span>
   <span class="font12">bold </span>
   <span class="font12">commitment </span>
   <span class="font12">contribute </span>
   <span class="font12">courier; </span>
   <span class="font12">current </span>
   <span class="font12">currently </span>
   <span class="font12">diseases, </span>
   <span class="font12">em; </span>
   <span class="font12">ensure </span>
   <span class="font12">entities, </span>
   <span class="font12">essential </span>
   <span class="font12">grant </span>
   <span class="font12">healthcare </span>
   <span class="font12">initial </span>
   <span class="font12">initiative </span>
   <span class="font12">loa </span>
   <span class="font12">model </span>
   <span class="font12">non-profit </span>
   <span class="font12">onchocerciasis </span>
   <span class="font12">organizations </span>
   <span class="font12">priorities </span>
   <span class="font12">programs </span>
   <span class="font12">protein </span>
   <span class="font12">provides </span>
   <span class="font12">pt;} </span>
   <span class="font12">public-private </span>
   <span class="font12">relevant </span>
   <span class="font12">role </span>
   <span class="font12">scientific </span>
   <span class="font12">screening </span>
   <span class="font12">significant </span>
   <span class="font12">statin </span>
   <span class="font12">targeted </span>
  </p>
 </body>
</html>
